Inventor · disambiguated record
Aigars Jirgensons
Also filed as: JIRGENSONS AIGARS
13 granted patents·7 pending applications·331 citations·filing 1998–2020
88Inventor score
Files withMERZ PHARMA GMBH & CO KGAA11OXFORD DRUG DESIGN LTD3GOLD MARKUS-RENE2MERZ & CO GMBH & CO2DICOTYLEDON AB1
Top patents by PatentIndex Score
20 records- 0196US6034134A1-Amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Mar 7, 2000·238 cites·22 claims
- 0284US6071966A1-amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Jun 6, 2000·74 cites·12 claims
- 0378US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 0467US7598384B2Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Oct 6, 2009·1 cites·77 claims
- 0566US6602862B11-Amino-alkylcyclohexanes as trypanocidal agentsMERZ PHARMA GMBH & CO KGAA·Filed 2000·Granted Aug 5, 2003·3 cites·16 claims
- 0662US7022729B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2003·Granted Apr 4, 2006·1 cites·3 claims
- 0761US2009227582A1Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 0856US2007185151A1Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 0955US7238703B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jul 3, 2007·0 cites·3 claims
- 1053US7550482B2Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jun 23, 2009·0 cites·11 claims
- 1153US2007105961A11-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2006·Application pending·0 cites
- 1246US2010311741A1Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic AgentsINHIBOX LTD·Filed 2008·Application pending·0 cites
- 1345US2011288336A1Method for producing memantineGOLD MARKUS-RENE·Filed 2009·Application pending·0 cites
- 1443US11072581B2N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitorsOXFORD DRUG DESIGN LTD·Filed 2016·Granted Jul 27, 2021·0 cites·19 claims
- 1543US2010298442A11-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2010·Application pending·0 cites
- 1642US2006004001A1Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 1740US8692021B2Method of preparing Neramexane or a salt thereofGOLD MARKUS-RENE·Filed 2010·Granted Apr 8, 2014·0 cites·18 claims
- 1837US12247004B22-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic useOXFORD DRUG DESIGN LTD·Filed 2020·Granted Mar 11, 2025·0 cites·24 claims
- 1935US11802110B22-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetaseOXFORD DRUG DESIGN LTD·Filed 2017·Granted Oct 31, 2023·0 cites·28 claims
- 2027US9403841B2Phragamalin limonoids for the treatment of sexual dysfunctionDICOTYLEDON AB·Filed 2013·Granted Aug 2, 2016·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →